Polyrizon

Polyrizon Current Liabilities

The Current Liabilities of Polyrizon (PLRZ) as of Oct 21, 2026 is 886,000.00 USD. In the previous year, Current Liabilities was 522,000.00 USD — a change of 69.73% (higher).

Current Liabilities

886,000.00USD

YoY

69.73%

Last updated:

Current Liabilities of Polyrizon is 2025 886,000.00 USD. Current Liabilities of Polyrizon was 2024 522,000.00 USD. It decreases by 69.73% higher compared to the previous year.

The Polyrizon Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2020
8,000.00 USD
Jan 1, 2021
864,000.00 USD
Jan 1, 2022
2.00 M USD
Jan 1, 2023
699,000.00 USD
Jan 1, 2024
522,000.00 USD
Jan 1, 2025
886,000.00 USD
The Polyrizon Current Liabilities history
YEARCurrent LiabilitiesYoY
886,000.00USD+69.73%
522,000.00USD-25.32%
699,000.00USD-65.02%
2.00 MUSD+131.25%
864,000.00USD+10,700.00%
8,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

Current Liabilities of Polyrizon is 886,000.00 USD in 2025.

Current Liabilities of Polyrizon changed from 522,000.00 USD to 886,000.00 USD, representing a 69.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Polyrizon since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Polyrizon historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Polyrizon

All Key Metrics — Polyrizon